Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
04, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
In Part 1, well explore key considerations for identifying appropriate GLP-1 candidates and highlight the importance of setting realistic weight loss expectations
One study found that 90% of individuals experienced adverse side effects in the first eight weeks of treatment, while another study found that 70% of diabetes patients discontinued use after 2 years due to feeling chronically sick
Atherosclerosis 232 , 156164 (2014)
Other possible side effects from GLP-1 medications While not nearly as common, some people may experience other significant side effects with certain GLP-1 medications, such as: Cholecystitis
Lack of patient education or awareness: Many patients are unaware of how these medications work, how to manage side effects, or how to navigate the complexities of insurance coverage
